Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combination

Chest

Volumn 141, Issue 5, 2012, Pages 1134-1136

  Cazzola, Mario ^a,b   Matera, Maria Gabriella ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FORMOTEROL; LONG ACTING DRUG; SALMETEROL;

ASTHMA; BLOOD GAS TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ANTAGONISM; DRUG EFFECT; EDITORIAL; HUMAN; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG HEMODYNAMICS; LUNG VENTILATION PERFUSION RATIO; PRESCRIPTION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 84860555521     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2497     Document Type: Editorial

References (11)

1. Cazzola M, Noschese P, De Michele F, D'Amato G, Matera MG. Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. Respir Med. 2006;100(2):212-217. (Pubitemid 43078971)
2. 2-agonists in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2007;176(4):350-355.
3. Kumar SD, Brieva JL, Danta I, Wanner A. Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma. Am J Respir Crit Care Med.2000;161(3 Pt 1):918-921. (Pubitemid 30171752)
4. Horvath G, Lieb T, Conner GE, Salathe M, Wanner A. Steroid sensitivity of norepinephrine uptake by human bronchial arterial and rabbit aortic smooth muscle cells. Am J Respir Cell Mol Biol. 2001;25(4):500-506. (Pubitemid 33037683)
5. Salvi SS. Alpha1-adrenergic hypothesis for pulmonary hypertension. Chest. 1999;115(6):1708-1719.
6. Andò F, Ruggeri P, Girbino G, Cazzola M. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD. Respir Med. 2008;102(6):815-818.
7. Mendes ES, Rebolledo P, Wanner A. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma. Chest. 2012;141(5):1184-1189.
8. Cazzola M, Mantero A, Santus P, et al. Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients. Pulm Pharmacol Ther. 2007;20(3):258-264. (Pubitemid 46240952)
9. Cazzola M, Pasqua F, Ferri L, Biscione G, Cardaci V, Matera MG. Rapid onset of bronchodilation with formoterol/beclomethasone modulite and formoterol/budesonide turbuhaler as compared to formoterol alone in patients with COPD. Pulm Pharmacol Ther. 2011;24(1):118-122.
10. Bhattacharya J. Lung neovascularization: a tale of two circulations. Am J Physiol Lung Cell Mol Physiol. 2008;294(3): L417-L418. (Pubitemid 351468840)
11. Horvath G, Mendes ES, Schmid N, et al. The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. J Allergy Clin Immunol. 2007;120(5):1103-1109. (Pubitemid 350029910)